Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 3 / Research Article
Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size Table 3 Predictors of DFS in NSCLC patients.
Variable Univariate analysis Multivariate analysis HR 95 CI P HR 95 CI P Age group (≤50 /50-65/≥65 years old) 0.505 0.292-0.871 0.014 0.272 0.141-0.525 0.000 ECOG (=0/1/2) 1.936 0.877-4.276 0.102 5.161 1.932-13.791 0.001 lymphatic metastasis(≥5/<5) 0.043 0.-4536.482 0.595 4.101 1.531-10.989 0.005 BMI(<20/20-24/>24) 0.351 0.145-0.851 0.021 0.259 0.91-0.734 0.011 Occupation (peasant/ worker/ cadre/ intellectual) 1.483 0.549-4.005 0.437 4.426 1.274-15.381 0.019 KPS (<80/≥80) 0.471 0.235-0.943 0.034 Smoke (no/yes) 1.260 0.811-1.957 0.303 Tumor size (≥5/<5) 1.115 0.570-2.180 0.750 Clinical stages (IIA /IIB/IIIA) 1.139 0.748-1.735 0.543 Treatment (TCM user/non-TCM user) 0.409 0.200-0.837 0.014